High Staked: Quarterly Report Card
Share on twitter
Share on facebook

By now, nearly the end of Week 3, you have a pretty good idea where your teams are heading and who your weekly starters are. Because the FFPC Main Event season is only 11 games, the end of tonight’s Pittsburgh-Tampa game marks more than a quarter of the way through the schedule, when optimistic owners dare to start eyeing that $250,000 grand prize while depressed ones imagine their buy-in fees swirling down the toilet.

Please subscribe to Read The Entire Article!

 

What’s included in your subscription??

  • Exclusive Access to RotoViz Study Hall
    • A treasure trove of our most insightful articles that will teach you the metrics that matter, time-tested winning strategies, the approaches that will give you an edge, and teach you how to be an effective fantasy manager.
  • Revolutionary Tools
    • Including the NFL Stat Explorer, Weekly GLSP Projections, NCAA Prospect Box Score Scout, Combine Explorer, Range of Outcomes App, DFS Lineup Optimizer, Best Ball Suite,and many, many, more.
  • Groundbreaking Articles
    • RotoViz is home of the original Zero-RB article and continues to push fantasy gamers forward as the go-to destination for evidence-based analysis and strategic advantages.
  • Weekly Projections
    • Built using RotoViz’s unique GLSP approach.
  • Expert Rankings
  • NFL, CFB, and PGA coverage included in all subscription levels.
  • And a whole lot more…

Monty Phan

Lead writer focusing on high-stakes fantasy football. 2017 FFPC Main Event regular season points champion. 4-time FFPC Main Event league winner. 2018 FFPC Bare Knuckle league champ.

The Blitz

What we do
Connect
Support

rotovizmain@gmail.com

Sign-up today for our free Premium Email subscription!

© 2020 RotoViz. All rights Reserved.

Welcome Back to RotoViz...

– IF YOU HAVE ISSUES LOGGING IN PLEASE CONTACT ROTOVIZMAIN@GMAIL.COM

– PLEASE NOTE THAT ROTOVIZ USES WORDPRESS FOR ACCOUNT MANAGEMENT. IF RESETTING YOUR PASSWORD YOU MAY BE FOWARDED TO A WORDPRESS PAGE.